Erika Hamilton MD, FASCO
@erikahamilton9.bsky.social
Director of Breast Cancer Research Program at Sarah Cannon Research Institute | Wife | Mom to 2 Girls | Tweets are My Own #Oncology #BCSM, #Cancer.
Recently, I had the chance to reflect on chairing #ASCO2025, the evolving landscape of breast cancer research, and why patient-centered innovation matters more than ever.
#SCRIOncologyPartners
📖 www.emjreviews.com/en-us/amj/on...
#Oncology #BreastCancer #ClinicalTrials #Leadership
#SCRIOncologyPartners
📖 www.emjreviews.com/en-us/amj/on...
#Oncology #BreastCancer #ClinicalTrials #Leadership
ASCO 2025 Interview: Erika Hamilton
As practicing oncologists, we can get bogged down in our individual practices and thus have trouble seeing the bigger picture in...
www.emjreviews.com
July 22, 2025 at 3:37 PM
Recently, I had the chance to reflect on chairing #ASCO2025, the evolving landscape of breast cancer research, and why patient-centered innovation matters more than ever.
#SCRIOncologyPartners
📖 www.emjreviews.com/en-us/amj/on...
#Oncology #BreastCancer #ClinicalTrials #Leadership
#SCRIOncologyPartners
📖 www.emjreviews.com/en-us/amj/on...
#Oncology #BreastCancer #ClinicalTrials #Leadership
Reposted by Erika Hamilton MD, FASCO
VERITAC-2 shows vepdegestrant improves PFS after CDK4/6i among pts with HR+ mutESR1 MBc, from 2.1 months to 5.0 months. @erikahamilton9.bsky.social
@oncoalert.bsky.social #ASCO25
@oncoalert.bsky.social #ASCO25
May 31, 2025 at 7:00 PM
VERITAC-2 shows vepdegestrant improves PFS after CDK4/6i among pts with HR+ mutESR1 MBc, from 2.1 months to 5.0 months. @erikahamilton9.bsky.social
@oncoalert.bsky.social #ASCO25
@oncoalert.bsky.social #ASCO25
Reposted by Erika Hamilton MD, FASCO
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
May 23, 2025 at 10:05 AM
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
Another positive trial in #bcsm, TDXd followed by THP beats ddAC-THP in neoadjuvant HER-2+ early breast cancer.
We've seen a lot of positive TDXd results, but this is the FIRST 🥇in the early stage setting!
@oncbrothers.bsky.social
@oncoalert.bsky.social
www.astrazeneca.com/media-centre...
We've seen a lot of positive TDXd results, but this is the FIRST 🥇in the early stage setting!
@oncbrothers.bsky.social
@oncoalert.bsky.social
www.astrazeneca.com/media-centre...
Enhertu followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete response in patients with high-risk HER2-positive early-stage breas...
www.astrazeneca.com
May 7, 2025 at 1:01 PM
Another positive trial in #bcsm, TDXd followed by THP beats ddAC-THP in neoadjuvant HER-2+ early breast cancer.
We've seen a lot of positive TDXd results, but this is the FIRST 🥇in the early stage setting!
@oncbrothers.bsky.social
@oncoalert.bsky.social
www.astrazeneca.com/media-centre...
We've seen a lot of positive TDXd results, but this is the FIRST 🥇in the early stage setting!
@oncbrothers.bsky.social
@oncoalert.bsky.social
www.astrazeneca.com/media-centre...
Maple was very interested in the Derby 🐎
May 4, 2025 at 4:32 PM
Maple was very interested in the Derby 🐎
Reposted by Erika Hamilton MD, FASCO
Molecular Profiling, Endocrine Sensitivity Are Key to Managing Later-Line HR+/HER2-Negative Breast Cancer @erikahamilton9.bsky.social #bcsm #oncology www.onclive.com/view/molecul...
Molecular Profiling, Endocrine Sensitivity Are Key to Managing Later-Line HR+/HER2-Negative Breast Cancer
Erika P. Hamilton, MD, discusses the current role of CDK4/6 inhibitors and evolving targeted therapies in advanced HR-positive, HER2-negative breast cancer.
www.onclive.com
April 16, 2025 at 6:25 PM
Molecular Profiling, Endocrine Sensitivity Are Key to Managing Later-Line HR+/HER2-Negative Breast Cancer @erikahamilton9.bsky.social #bcsm #oncology www.onclive.com/view/molecul...
Look at what our practice did for us for Doctor's Day this year? Seriously so cute and thoughtful.
Definitely my best Doctor's Day ever! Thank you SCRI Oncology Partners!
Definitely my best Doctor's Day ever! Thank you SCRI Oncology Partners!
March 31, 2025 at 5:00 PM
Look at what our practice did for us for Doctor's Day this year? Seriously so cute and thoughtful.
Definitely my best Doctor's Day ever! Thank you SCRI Oncology Partners!
Definitely my best Doctor's Day ever! Thank you SCRI Oncology Partners!
#JSMO25 was amazing!
💪🏼 Had a fantastic session led by Makiko Ono on gender balance in oncology,
⭐️ a great joint @ascocancer.bsky.social / JSMO session on undruggable targets,
🌹 a beautiful Presidential Dinner....
🇯🇵 and got to squeeze in a visit to a shrine!
💪🏼 Had a fantastic session led by Makiko Ono on gender balance in oncology,
⭐️ a great joint @ascocancer.bsky.social / JSMO session on undruggable targets,
🌹 a beautiful Presidential Dinner....
🇯🇵 and got to squeeze in a visit to a shrine!
March 7, 2025 at 9:00 PM
#JSMO25 was amazing!
💪🏼 Had a fantastic session led by Makiko Ono on gender balance in oncology,
⭐️ a great joint @ascocancer.bsky.social / JSMO session on undruggable targets,
🌹 a beautiful Presidential Dinner....
🇯🇵 and got to squeeze in a visit to a shrine!
💪🏼 Had a fantastic session led by Makiko Ono on gender balance in oncology,
⭐️ a great joint @ascocancer.bsky.social / JSMO session on undruggable targets,
🌹 a beautiful Presidential Dinner....
🇯🇵 and got to squeeze in a visit to a shrine!
It's almost like we knew we didn't want measles and all were getting vaccinated so we didn't have to live like it was in 1950 🤷🏼♀️
PSA: anti-vax isn't cool, it isn't protecting your family. You and your family don't want complications from diseases that can be prevented.
PSA: anti-vax isn't cool, it isn't protecting your family. You and your family don't want complications from diseases that can be prevented.
February 26, 2025 at 4:16 PM
It's almost like we knew we didn't want measles and all were getting vaccinated so we didn't have to live like it was in 1950 🤷🏼♀️
PSA: anti-vax isn't cool, it isn't protecting your family. You and your family don't want complications from diseases that can be prevented.
PSA: anti-vax isn't cool, it isn't protecting your family. You and your family don't want complications from diseases that can be prevented.
Happy to have participated in #SERENA6, using ctDNA to tailor an early switch strategy for metastatic HR+ disease.
Could make ctDNA actually ACTIONable in breast for the first time!
www.astrazeneca.com/media-centre...
Could make ctDNA actually ACTIONable in breast for the first time!
www.astrazeneca.com/media-centre...
Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumou...
www.astrazeneca.com
February 26, 2025 at 2:01 PM
Happy to have participated in #SERENA6, using ctDNA to tailor an early switch strategy for metastatic HR+ disease.
Could make ctDNA actually ACTIONable in breast for the first time!
www.astrazeneca.com/media-centre...
Could make ctDNA actually ACTIONable in breast for the first time!
www.astrazeneca.com/media-centre...
Asia Pacific Breast Cancer Symposium
February 22, 2025 at 11:02 PM
Asia Pacific Breast Cancer Symposium
Reposted by Erika Hamilton MD, FASCO
Proud to collaborate with @scrinetwork.bsky.social at Great Debates in Solid Tumors!
Join Co-Chairs @erikahamilton9.bsky.social & @drkatymoore.bsky.social, plus Andrew McKenzie PhD, & @viveksubbiah.bsky.social, leading key discussions on solid tumors.
🔗 gdsolidtumors.com
#Oncology #CancerResearch
Join Co-Chairs @erikahamilton9.bsky.social & @drkatymoore.bsky.social, plus Andrew McKenzie PhD, & @viveksubbiah.bsky.social, leading key discussions on solid tumors.
🔗 gdsolidtumors.com
#Oncology #CancerResearch
February 18, 2025 at 9:11 PM
Proud to collaborate with @scrinetwork.bsky.social at Great Debates in Solid Tumors!
Join Co-Chairs @erikahamilton9.bsky.social & @drkatymoore.bsky.social, plus Andrew McKenzie PhD, & @viveksubbiah.bsky.social, leading key discussions on solid tumors.
🔗 gdsolidtumors.com
#Oncology #CancerResearch
Join Co-Chairs @erikahamilton9.bsky.social & @drkatymoore.bsky.social, plus Andrew McKenzie PhD, & @viveksubbiah.bsky.social, leading key discussions on solid tumors.
🔗 gdsolidtumors.com
#Oncology #CancerResearch
My kid has to select the proper US state as an online interactive map calls them out in random order in under 2 minutes.
I can't even come close. It's near impossible when you have to zoom in on small states in the NE to accurately press the right tiiiny state on an iPad and then zoom back out.
I can't even come close. It's near impossible when you have to zoom in on small states in the NE to accurately press the right tiiiny state on an iPad and then zoom back out.
February 12, 2025 at 12:17 AM
My kid has to select the proper US state as an online interactive map calls them out in random order in under 2 minutes.
I can't even come close. It's near impossible when you have to zoom in on small states in the NE to accurately press the right tiiiny state on an iPad and then zoom back out.
I can't even come close. It's near impossible when you have to zoom in on small states in the NE to accurately press the right tiiiny state on an iPad and then zoom back out.
Reposted by Erika Hamilton MD, FASCO
TODAY🚨 #OncoAlertColloquium #BreastCancer
✅FREE REGISTRATION👉 buff.ly/4jJy808
✅ACCESS👉 vimeo.com/event/4875736
⭐️A PASSWORD IS NEEDED, hence REGISTRATION IS NEEDED
@erikahamilton9.bsky.social
@hoperugo.bsky.social
@drsgraff.bsky.social
@maryamlustberg.bsky.social
@elisaagostinetto.bsky.social
✅FREE REGISTRATION👉 buff.ly/4jJy808
✅ACCESS👉 vimeo.com/event/4875736
⭐️A PASSWORD IS NEEDED, hence REGISTRATION IS NEEDED
@erikahamilton9.bsky.social
@hoperugo.bsky.social
@drsgraff.bsky.social
@maryamlustberg.bsky.social
@elisaagostinetto.bsky.social
February 5, 2025 at 9:38 AM
TODAY🚨 #OncoAlertColloquium #BreastCancer
✅FREE REGISTRATION👉 buff.ly/4jJy808
✅ACCESS👉 vimeo.com/event/4875736
⭐️A PASSWORD IS NEEDED, hence REGISTRATION IS NEEDED
@erikahamilton9.bsky.social
@hoperugo.bsky.social
@drsgraff.bsky.social
@maryamlustberg.bsky.social
@elisaagostinetto.bsky.social
✅FREE REGISTRATION👉 buff.ly/4jJy808
✅ACCESS👉 vimeo.com/event/4875736
⭐️A PASSWORD IS NEEDED, hence REGISTRATION IS NEEDED
@erikahamilton9.bsky.social
@hoperugo.bsky.social
@drsgraff.bsky.social
@maryamlustberg.bsky.social
@elisaagostinetto.bsky.social
Soooooo....I guess my addictive habit of buying cheap light-up seasonal decorations from Temu for less than $5 is drying up next week, huh?
Have to admit, I've been super pleasantly surprised by this stuff.
Have to admit, I've been super pleasantly surprised by this stuff.
February 2, 2025 at 6:43 PM
Soooooo....I guess my addictive habit of buying cheap light-up seasonal decorations from Temu for less than $5 is drying up next week, huh?
Have to admit, I've been super pleasantly surprised by this stuff.
Have to admit, I've been super pleasantly surprised by this stuff.
Reposted by Erika Hamilton MD, FASCO
OncoAlert🚨Network with our partners at ESSO, ESGO, MASCC & SIOG invite you to the #OncoAlertColloquium
NEXT WEEK!!
FREE REGISTRATION HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
NEXT WEEK!!
FREE REGISTRATION HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
January 29, 2025 at 3:37 PM
OncoAlert🚨Network with our partners at ESSO, ESGO, MASCC & SIOG invite you to the #OncoAlertColloquium
NEXT WEEK!!
FREE REGISTRATION HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
NEXT WEEK!!
FREE REGISTRATION HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
Reposted by Erika Hamilton MD, FASCO
This is huge.
The European equivalent to the FDA has said enough to the propaganda machine X.
Others will follow.
#medsky #oncosky
www.reuters.com/world/europe...
The European equivalent to the FDA has said enough to the propaganda machine X.
Others will follow.
#medsky #oncosky
www.reuters.com/world/europe...
EU medicines agency quits X, moves to Bluesky
The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media platform that some have criticised for its content.
www.reuters.com
January 27, 2025 at 10:39 PM
This is huge.
The European equivalent to the FDA has said enough to the propaganda machine X.
Others will follow.
#medsky #oncosky
www.reuters.com/world/europe...
The European equivalent to the FDA has said enough to the propaganda machine X.
Others will follow.
#medsky #oncosky
www.reuters.com/world/europe...
DB-06 #TDXD approved for HER-2 "ultra low" (IHC but staining) breast cancer, and 1st line moving this drug up.
#bcsm
@oncoalert.bsky.social
www.astrazeneca.com/media-centre...
#bcsm
@oncoalert.bsky.social
www.astrazeneca.com/media-centre...
Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies
www.astrazeneca.com
January 27, 2025 at 11:19 PM
DB-06 #TDXD approved for HER-2 "ultra low" (IHC but staining) breast cancer, and 1st line moving this drug up.
#bcsm
@oncoalert.bsky.social
www.astrazeneca.com/media-centre...
#bcsm
@oncoalert.bsky.social
www.astrazeneca.com/media-centre...
Reposted by Erika Hamilton MD, FASCO
The tiny amount of aluminum helps make certain vaccines even more effective& has a strong safety record. “In the first six months of babies’ lives, vaccines expose them to roughly 4.4 milligrams of aluminum. One slice of American cheese, by contrast, can contain as much as 50 milligrams of aluminum”
Yes, Some Vaccines Contain Aluminum. That’s a Good Thing.
R.F.K. Jr. and others have blamed the ingredient for allergies and other illnesses. Scientists say it actually bolsters the immune response.
www.nytimes.com
January 24, 2025 at 12:52 PM
The tiny amount of aluminum helps make certain vaccines even more effective& has a strong safety record. “In the first six months of babies’ lives, vaccines expose them to roughly 4.4 milligrams of aluminum. One slice of American cheese, by contrast, can contain as much as 50 milligrams of aluminum”
Anyone need motivation for a flu shot?
My middle school daughter's basketball game for today was postponed to next week because the opposing team doesn't have 5 players to dress that don't currently have the flu. 😷
My middle school daughter's basketball game for today was postponed to next week because the opposing team doesn't have 5 players to dress that don't currently have the flu. 😷
January 24, 2025 at 12:26 PM
Anyone need motivation for a flu shot?
My middle school daughter's basketball game for today was postponed to next week because the opposing team doesn't have 5 players to dress that don't currently have the flu. 😷
My middle school daughter's basketball game for today was postponed to next week because the opposing team doesn't have 5 players to dress that don't currently have the flu. 😷
Fantastic thread about why freezing the NIH has far reaching consequences.
Why should the public care about the freeze on the NIH? Aside from the need for scientific pursuits to make our society better…
-For every dollar we invest in NIH research, there is a $2.5 return.
-Research dollars help fund universities that employ non-academics. (1/)
-For every dollar we invest in NIH research, there is a $2.5 return.
-Research dollars help fund universities that employ non-academics. (1/)
January 24, 2025 at 2:04 AM
Fantastic thread about why freezing the NIH has far reaching consequences.
Yes, I have to confirm this is completely normal. Been through this stage x 2.
In better news, it tends to go away in half a year.
In better news, it tends to go away in half a year.
My 5 year old is learning punctuation and whenever he sees an exclamation point at the end of the sentence he just screams the word that precedes it
January 24, 2025 at 2:03 AM
Yes, I have to confirm this is completely normal. Been through this stage x 2.
In better news, it tends to go away in half a year.
In better news, it tends to go away in half a year.
Hot off the press 📰 - we have a 2nd TROP-2 ADC for #bcsm
Saci: D#1,8
-💩 low WBC
Dato: q3 wks
- 👄 sores
Nice to have options for our patients
@oncoalert
www.reuters.com/business/hea...
Saci: D#1,8
-💩 low WBC
Dato: q3 wks
- 👄 sores
Nice to have options for our patients
@oncoalert
www.reuters.com/business/hea...
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday.
www.reuters.com
January 17, 2025 at 7:02 PM
Hot off the press 📰 - we have a 2nd TROP-2 ADC for #bcsm
Saci: D#1,8
-💩 low WBC
Dato: q3 wks
- 👄 sores
Nice to have options for our patients
@oncoalert
www.reuters.com/business/hea...
Saci: D#1,8
-💩 low WBC
Dato: q3 wks
- 👄 sores
Nice to have options for our patients
@oncoalert
www.reuters.com/business/hea...
Who has tried to add Palbo to maintenance let + HP?
Know it isn't "approved yet", but wasn't successful. Anyone been successful for coverage yet with #PATINA?
@ptarantinomd.bsky.social
@hoperugo.bsky.social
@stolaney1.bsky.social
@vkaklamani.bsky.social
@jochien.bsky.social
Know it isn't "approved yet", but wasn't successful. Anyone been successful for coverage yet with #PATINA?
@ptarantinomd.bsky.social
@hoperugo.bsky.social
@stolaney1.bsky.social
@vkaklamani.bsky.social
@jochien.bsky.social
January 13, 2025 at 12:29 PM
Who has tried to add Palbo to maintenance let + HP?
Know it isn't "approved yet", but wasn't successful. Anyone been successful for coverage yet with #PATINA?
@ptarantinomd.bsky.social
@hoperugo.bsky.social
@stolaney1.bsky.social
@vkaklamani.bsky.social
@jochien.bsky.social
Know it isn't "approved yet", but wasn't successful. Anyone been successful for coverage yet with #PATINA?
@ptarantinomd.bsky.social
@hoperugo.bsky.social
@stolaney1.bsky.social
@vkaklamani.bsky.social
@jochien.bsky.social
Reposted by Erika Hamilton MD, FASCO
The OncoAlert🚨 Network along with our partners at
ESSO, ESGO, MASCC & SIOG
invite you to the #OncoAlertColloquium
REGISTER for FREE HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
ESSO, ESGO, MASCC & SIOG
invite you to the #OncoAlertColloquium
REGISTER for FREE HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
January 10, 2025 at 6:23 PM
The OncoAlert🚨 Network along with our partners at
ESSO, ESGO, MASCC & SIOG
invite you to the #OncoAlertColloquium
REGISTER for FREE HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
ESSO, ESGO, MASCC & SIOG
invite you to the #OncoAlertColloquium
REGISTER for FREE HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social